Xaga Surgical

Xaga Surgical, a spinoff from Lund University, specializes in developing advanced medical needles designed to minimize bacterial transfer and reduce infection risks, particularly in the context of rising antibiotic resistance. The company primarily serves healthcare providers and medical institutions, focusing on improving patient safety during procedures such as prostate biopsies. Operating within the medical device market, Xaga Surgical's business model revolves around the development, patenting, and commercialization of its proprietary needle technology. Revenue is generated through the sale of these specialized needles to hospitals and clinics, as well as potential licensing agreements. The company's innovative approach addresses a critical need in modern healthcare, offering a solution that significantly lowers the risk of severe infections like sepsis.

Keywords: medical needles, infection control, antibiotic resistance, prostate biopsy, patient safety, healthcare innovation, bacterial transfer, sepsis prevention, medical devices, Lund University spinoff.